NEOCHEM — Neochem Bio Solutions Balance Sheet
0.000.00%
- IN₹1.92bn
- IN₹2.10bn
- IN₹1.11bn
Annual balance sheet for Neochem Bio Solutions, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.483 | 3.51 | 0.55 | 1.81 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 166 | 189 | 265 | 509 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 320 | 387 | 531 | 859 |
| Net Property, Plant And Equipment | 147 | 188 | 187 | 200 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 506 | 641 | 789 | 1,171 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 292 | 329 | 439 | 359 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 426 | 521 | 591 | 383 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 80.5 | 120 | 198 | 788 |
| Total Liabilities & Shareholders' Equity | 506 | 641 | 789 | 1,171 |
| Total Common Shares Outstanding |